Metraipolis › archive › dc_e86024bb384c

Decrease in Urinary Tract Infections Following Switch From Anti-Interleukin-6 Monoclonal Antibody to Ravulizumab in a Patient With Neuromyelitis Optica… — Europe PMC PMID:41133088

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41133088
DOI
10.7759/cureus.92891
License (as archived)
solo-consultazione
Archived
2026-11-09T20:09:36.081Z
SHA-256 of the archived text
9755038889bbf5ec74bd53e83edd69b91f0fa81470b37662a725f8680c136fcc
Stable URL of this page
https://metraipolis.com/documento/dc_e86024bb384c

How to cite

Decrease in Urinary Tract Infections Following Switch From Anti-Interleukin-6 Monoclonal Antibody to Ravulizumab in a Patient With Neuromyelitis Optica… — Europe PMC PMID:41133088 — Europe PMC (en), https://europepmc.org/article/MED/41133088 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e86024bb384c (Metraipolis archive dc_e86024bb384c, sha256 9755038889bbf5ec74bd53e83edd69b91f0fa81470b37662a725f8680c136fcc)
BibTeX
@misc{dce86024bb384c,
  title = {Decrease in Urinary Tract Infections Following Switch From Anti-Interleukin-6 Monoclonal Antibody to Ravulizumab in a Patient With Neuromyelitis Optica… — Europe PMC PMID:41133088},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41133088},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e86024bb384c; sha256 9755038889bbf5ec74bd53e83edd69b91f0fa81470b37662a725f8680c136fcc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41133088. Agents can read the archived copy with the MCP tool read_document.